Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Cas No. | 950736-05-7 |
|---|---|
| Purity | ≥98% |
| Formula | C29H24F3N5O |
| Formula Wt. | 515.54 |
| IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
| Solubility | DMSO: ≥ 53 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
Endogenous pteridine metabolite of GTP.
Aldose reductase inhibitor.
Carbonic anhydrase inhibitor.
Prolyl hydroxylase inhibitor.
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
SERM.
Caspase 9 substrate.
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Nrf2-Keap1-ARE complex activator.
GPR17 agonist, NMDA and fructose 1,6-bisphospha...
Triterpene saponin found in Bupleurum.
Steroidal saponin found in Dioscorea.
H1 histamine and LT antagonist, PDE inhibitor.<...
Impurity of rapamycin
Nedd8-activating enzyme inhibitor.
Endogenous opioid peptide derived from the β-c...
Azoxanthone derivative; S100A12 and S100A13 inh...
Nucleoside (deoxyadenosine) analog; DNA chain t...